These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1032 related articles for article (PubMed ID: 28004121)

  • 81. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.
    Fulzele SV; Chatterjee A; Shaik MS; Jackson T; Ichite N; Singh M
    Anticancer Drugs; 2007 Jan; 18(1):65-78. PubMed ID: 17159504
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Phloretin induces apoptosis of non-small cell lung carcinoma A549 cells via JNK1/2 and p38 MAPK pathways.
    Min J; Huang K; Tang H; Ding X; Qi C; Qin X; Xu Z
    Oncol Rep; 2015 Dec; 34(6):2871-9. PubMed ID: 26503828
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Recombinant adenoviruses expressing TRAIL demonstrate antitumor effects on non-small cell lung cancer (NSCLC).
    Yang F; Shi P; Xi X; Yi S; Li H; Sun Q; Sun M
    Med Oncol; 2006; 23(2):191-204. PubMed ID: 16720919
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A deuterated analog of dasatinib disrupts cell cycle progression and displays anti-non-small cell lung cancer activity in vitro and in vivo.
    Ling C; Chen G; Chen G; Zhang Z; Cao B; Han K; Yin J; Chu A; Zhao Y; Mao X
    Int J Cancer; 2012 Nov; 131(10):2411-9. PubMed ID: 22362357
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Combination of TRAIL and actinomycin D liposomes enhances antitumor effect in non-small cell lung cancer.
    Guo L; Fan L; Ren J; Pang Z; Ren Y; Li J; Wen Z; Qian Y; Zhang L; Ma H; Jiang X
    Int J Nanomedicine; 2012; 7():1449-60. PubMed ID: 22619505
    [TBL] [Abstract][Full Text] [Related]  

  • 86. β-catenin decreases acquired TRAIL resistance in non-small-cell lung cancer cells by regulating the redistribution of death receptors.
    You C; Zhang S; Sun Y; Zhang S; Tang G; Tang F; Liu X; Xiao Y; Zhang J; Gong Y; Xie C
    Int J Oncol; 2018 Nov; 53(5):2258-2268. PubMed ID: 30132512
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Potential Antitumor Activity of SIM-89 in Non-Small Cell Lung Cancer Cells.
    Pei J; Chu T; Shao M; Teng J; Sha H; Gu A; Li R; Qian J; Mao W; Li Y; Han B
    Yonsei Med J; 2017 May; 58(3):581-591. PubMed ID: 28332364
    [TBL] [Abstract][Full Text] [Related]  

  • 88. VAOS, a novel vanadyl complexes of alginate saccharides, inducing apoptosis via activation of AKT-dependent ROS production in NSCLC.
    Zhou L; Yi Y; Yuan Q; Zhang J; Li Y; Wang P; Xu M; Xie S
    Free Radic Biol Med; 2018 Dec; 129():177-185. PubMed ID: 30223019
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A bispecific fusion protein and a bifunctional enediyne-energized fusion protein consisting of TRAIL, EGFR peptide ligand, and apoprotein of lidamycin against EGFR and DR4/5 show potent antitumor activity.
    Zhu D; Wang X; Shang Y; Li Y; Jiang W; Li L; Chen SZ
    Anticancer Drugs; 2015 Jan; 26(1):64-73. PubMed ID: 25122444
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Wogonoside induces apoptosis in human non-small cell lung cancer A549 cells by promoting mitochondria dysfunction.
    Luo M; Mo J; Yu Q; Zhou S; Ning R; Zhang Y; Su C; Wang H; Cui J
    Biomed Pharmacother; 2018 Oct; 106():593-598. PubMed ID: 29990847
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Se-methylselenocysteine inhibits the progression of non-small cell lung cancer via ROS-mediated NF-κB signaling pathway.
    Ge L; Liu P; Tian L; Li Y; Chen L
    Exp Cell Res; 2024 Jul; 440(1):114101. PubMed ID: 38815788
    [TBL] [Abstract][Full Text] [Related]  

  • 92. In vitro and in vivo antitumor activity of a novel semisynthetic derivative of cucurbitacin B.
    Silva IT; Carvalho A; Lang KL; Dudek SE; Masemann D; Durán FJ; Caro MS; Rapp UR; Wixler V; Schenkel EP; Simões CM; Ludwig S
    PLoS One; 2015; 10(2):e0117794. PubMed ID: 25674792
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation.
    Hsieh FS; Hung MH; Wang CY; Chen YL; Hsiao YJ; Tsai MH; Li JR; Chen LJ; Shih CT; Chao TI; Chen KF
    Lung Cancer; 2017 Oct; 112():81-89. PubMed ID: 29191605
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
    Song J; Ko HS; Sohn EJ; Kim B; Kim JH; Kim HJ; Kim C; Kim JE; Kim SH
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1188-91. PubMed ID: 24461294
    [TBL] [Abstract][Full Text] [Related]  

  • 95. An-te-xiao capsule inhibits tumor growth in non-small cell lung cancer by targeting angiogenesis.
    Han L; Wang JN; Cao XQ; Sun CX; Du X
    Biomed Pharmacother; 2018 Dec; 108():941-951. PubMed ID: 30372906
    [TBL] [Abstract][Full Text] [Related]  

  • 96. JS‑K induces G2/M phase cell cycle arrest and apoptosis in A549 and H460 cells via the p53/p21WAF1/CIP1 and p27KIP1 pathways.
    Song Z; Yin Y; Hao S; Wei J; Liu B; Huang X; Gao C; Zhu R; Liao W; Cai D
    Oncol Rep; 2019 Jun; 41(6):3475-3487. PubMed ID: 31002373
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Toxicological effects of NCKU-21, a phenanthrene derivative, on cell growth and migration of A549 and CL1-5 human lung adenocarcinoma cells.
    Liao HF; Pan CH; Chou PY; Chen YF; Wu TS; Sheu MJ; Wu CH
    PLoS One; 2017; 12(9):e0185021. PubMed ID: 28945763
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Role of elevated pressure in TRAIL-induced apoptosis in human lung carcinoma cells.
    Oh S; Kwon D; Lee HJ; Kim J; Lee E
    Apoptosis; 2010 Dec; 15(12):1517-28. PubMed ID: 20623193
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway.
    Lee YC; Lin HH; Hsu CH; Wang CJ; Chiang TA; Chen JH
    Eur J Pharmacol; 2010 Apr; 632(1-3):23-32. PubMed ID: 20097193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.